However, semaglutide is also used in other medications, such as Wegovy, which contains a higher dose and is approved specifically for weight loss
Low blood sugar (hypoglycemia)
Digestive/GI side effects are common: nausea, vomiting, diarrhea, constipation, delayed gastric emptying (gastroparesis) have all been documented
The assumption is often that once a goal weight or certain lab numbers are reached, the hard part is over and the results will hold
RETA GLP-3 10MG is a cutting-edge research compound for metabolic and weight regulation studies, is a promising synthetic peptide, a triple-agonist, that mimics three natural hormones (GLP-1, GIP, glucagon) to powerfully regulate metabolism, appetite, and energy use, showing significant promise in labs and research studies
The STEP-1 trial tested the effect of high-dose semaglutide to produce weight loss in people with obesity who do not have diabetes